Pharma Stock Roundup: AZN"s Leukemia Drug Wins FDA Nod, MRK"s Keytruda in Focus

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 1) read more.....»»

Zacks.....»»

Catalyst Pharmaceuticals Inc. shares plunged more than 40% in after-hours trading Monday afternoon, when the Food and Drug Administration appro.....»»

These A-list drugmakers must both contend with expiring patents, new drug uncertainties, and hungry competitors. But they're in different stages of their cyclical journeys......»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 25) read more.....»»

We expect passenger revenues to grow for airline companies that are schedu.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week hig.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 11) read more.....»»

Recro Pharma's stock price plummeted more than 34 percent to $6.41 per share Monday, the first day of trading after the Food and Drug Administration's rejection of the Malvern pharmaceutical company's new drug application for a non-opioid pain medic.....»»

Shares of Recro Pharma Inc. plummeted 46% to pace all premarket decliners Monday, after the specialty pharmaceutical company said it received a second "complete response letter" (CRL) from the Food and Drug Administ.....»»

Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Cli.....»»

Zacks.....»»

Adamis Pharmaceuticals Corp. said the U.S. Food and Drug Administration has accepted for review its New Drug Application for a naloxone injection product used to treat opioid overdoses......»»

Zacks.....»»

Zacks.....»»

Three pharma/biotech bigwigs are set to release .....»»

Aerpio Pharmaceuticals Inc (OTC: ARPO), an OTC-listed company specializing in drug development for ocular diseases, earned a bullish review Wednesday. The interest in the stock can only go higher, as the company seeks to up-list the shares.....»»

GW Pharmaceuticals PLC said Thursday it has won a unanimous recommendation from a U.S. Food and Drug Administration advisory committee for the approval of its cannabis-derived drug epidi.....»»

Geron's experimental blood cancer drug remains a top priority for the pharma behemoth Johnson & Johnson......»»

Zacks.....»»